Like what he just said, get the opportunity to be first line or second line administering cells to phenomia patients before ventilation,eartly interventation is KEY when inflamation is present for our tech, hopefully this is the opportunity for huge $$$ and Novartis partnership going forward.
Looking forward to them drilling down on data from unblinds.
I'm not going anywhere!
Patience holders.
Ann: Mesoblast Webcast, page-41
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |